Cite
MLA Citation
Mahir Karakas et al.. “Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial.” Lancet, vol. 10, no. 3, 2022, pp. 247–254. http://access.bl.uk/ark:/81055/vdc_100152620004.0x000007